Coeptis Pharmaceuticals is a pharmaceutical company which focuses on developing and marketing branded and generic pharmaceuticals.
Coeptis Pharmaceuticals has raised $5.7M in total funding. The most recent round was Series A. The last funding was announced in February 2025.
Coeptis Pharmaceuticals's investors include CJC.
Coeptis Pharmaceuticals is headquartered in Wexford, United States.
Coeptis Pharmaceuticals is a pharmaceutical company which focuses on developing and marketing branded and generic pharmaceuticals.
Coeptis Pharmaceuticals is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Coeptis Pharmaceuticals — Funding & Investors." VCBacked, February 6, 2025, https://www.vcbacked.co/company/coeptis-pharmaceuticals. Accessed August 1, 2026.
VCBacked. (2025). Coeptis Pharmaceuticals — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/coeptis-pharmaceuticals
{{cite web |title=Coeptis Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/coeptis-pharmaceuticals |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated